Breaking News, Collaborations & Alliances

Ardena, RiboPro Partner to Support RNA-based Treatments

Aims to deliver improvements to the global availability of RNA-based treatments and address a crucial skills gap.

Ardena, a contract development manufacturer of nanomedicine, has joined forces with mRNA and LNP technology specialists RiboPro to form a new strategic commercial alliance aimed at delivering improvements to the global availability of RNA-based health treatments and address a crucial skills gap in the industry.  The new alliance combines Ardena’s expertise in custom development and cGMP manufacturing of lipids and LNP-mRNA formulations with RiboPro’s portfolio of mRNA-related tech...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters